Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hofman

Showing results (31-40 of 551) with videos related to

Pageof 56
Sort By:
Cancers|August 15, 2017
ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily PracticePaul Hofman
Translational Lung Cancer Research|December 4, 2018
Tumor mutational burden assessment as a predictive biomarker for immunotherapy in lung cancer patients: getting ready for prime-time or not?Simon Heeke, Paul Hofman
Translational Lung Cancer Research|September 23, 2016
Pros: Can tissue biopsy be replaced by liquid biopsy?Marius Ilié, Paul Hofman
Expert Review of Molecular Diagnostics|April 25, 2019
Companion diagnostic tests for treatment of lung cancer patients: what are the current and future challenges?Paul Hofman, Fabrice Barlesi
Translational Lung Cancer Research|December 4, 2018
Spotlight on tumor mutational burden in patients with non-small cell lung carcinomaMarius Ilie, Paul Hofman
Journal of Thoracic Disease|December 23, 2017
Atezolizumab in advanced non-small cell lung cancerMarius Ilie, Paul Hofman
Methods in Molecular Biology (Clifton, N.J.)|September 5, 2019
EGFR Mutation Analysis in Non-small Cell Lung Carcinoma from Tissue Samples Using the Fully Automated Idylla™ qPCR SystemSimon Heeke, Paul Hofman
Annales De Pathologie|November 1, 2002
[Cytopathologist's role in detecting and identifying pathogens]Paul Hofman, Michel Huerre
Translational Lung Cancer Research|September 23, 2016
Rebuttal from Dr. Hofman and Dr. IliéMarius Ilié, Paul Hofman
Translational Lung Cancer Research|January 5, 2018
Reproducibility of PD-L1 assessment in non-small cell lung cancer-know your limits but never stop trying to exceed themMarius Ilie, Paul Hofman
Pageof 56

Showing results (31-40 of 551) with videos related to

Sort By:
Pageof 56
Cancers|August 15, 2017
ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily PracticePaul Hofman
Translational Lung Cancer Research|December 4, 2018
Tumor mutational burden assessment as a predictive biomarker for immunotherapy in lung cancer patients: getting ready for prime-time or not?Simon Heeke, Paul Hofman
Translational Lung Cancer Research|September 23, 2016
Pros: Can tissue biopsy be replaced by liquid biopsy?Marius Ilié, Paul Hofman
Expert Review of Molecular Diagnostics|April 25, 2019
Companion diagnostic tests for treatment of lung cancer patients: what are the current and future challenges?Paul Hofman, Fabrice Barlesi
Translational Lung Cancer Research|December 4, 2018
Spotlight on tumor mutational burden in patients with non-small cell lung carcinomaMarius Ilie, Paul Hofman
Journal of Thoracic Disease|December 23, 2017
Atezolizumab in advanced non-small cell lung cancerMarius Ilie, Paul Hofman
Methods in Molecular Biology (Clifton, N.J.)|September 5, 2019
EGFR Mutation Analysis in Non-small Cell Lung Carcinoma from Tissue Samples Using the Fully Automated Idylla™ qPCR SystemSimon Heeke, Paul Hofman
Annales De Pathologie|November 1, 2002
[Cytopathologist's role in detecting and identifying pathogens]Paul Hofman, Michel Huerre
Translational Lung Cancer Research|September 23, 2016
Rebuttal from Dr. Hofman and Dr. IliéMarius Ilié, Paul Hofman
Translational Lung Cancer Research|January 5, 2018
Reproducibility of PD-L1 assessment in non-small cell lung cancer-know your limits but never stop trying to exceed themMarius Ilie, Paul Hofman
Pageof 56